Published :
Tables : 68
Figures : 52
Category : Healthcare
No. of Pages : 232
Report Code : HC-U3206
Hemostasis (Coagulation) Analyzer Market is estimated to value over USD 6.7 billion by 2027 end with a CAGR of over 9.9% during the forecast period 2020 to 2027. The rising number of instances of blood related diseases which has led to an increase in the assignment of funds for establishing coagulation analyzers, thus aiding in the growth of the market. Moreover, a growing number of cases associated with cardiovascular and blood disorders along iwht the rising geriatric and obses population which are other important factors responsible for the Conversely, strict regulatory policies pertaining to the validation of medical devices has proven to be an obstacle, especially for new entrants and small scale players, which retraints the growth of the market. FutureWise Market Research has instantiated a report that provides an intricate analysis of Hemostasis (Coagulation) Analyzer Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Hemostasis (Coagulation) Analyzer Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Hemostasis (Coagulation) Analyzer Market: Alere Inc. Nihon Kohden Corporation Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.) Siemens Healthcare (A Division of Siemens AG) Sysmex Corporation Thermo Fisher Scientific Inc. Diagnostica Stago Sas Helena Laboratories Instrumentation Laboratory (A Division of the Werfen Group) International Technidyne Corporation (ITC) (Note: The list of the major players will be updated with the latest market scenario and trends) Hemostasis (Coagulation) Analyzer Market Segmentation: By Product Clinical Laboratory Analyzers Systems Automated Systems Semi-automated Systems Manual Systems Consumables Reagents Standards, Controls and Calibrations Analyzers for Point-of-Care Testing By Test Prothrombin Time Fibrinogen Activated Partial Thromboplastin Time Activated Clotting Time D Dimer Platelet Function Anti-factor Xa Heparin & Protamine Dose Response Test for ACT Other Coagulation Tests By Technology Mechanical Optical Electrochemical Other Technologies By End Users Clinical Laboratories POC Others End Users By Region North America Europe Asia-Pacific Latin America Middle East and Africa Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the Hemostasis (Coagulation) Analyzer Market By Product, By Test, By Technology, By End Users and By Region. To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The rising number of instances of blood related diseases which has led to an increase in the assignment of funds for establishing coagulation analyzers, thus aiding in the growth of the market. Moreover, a growing number of cases associated with cardiovascular and blood disorders along iwht the rising geriatric and obses population which are other important factors responsible for the Conversely, strict regulatory policies pertaining to the validation of medical devices has proven to be an obstacle, especially for new entrants and small scale players, which retraints the growth of the market.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Hemostasis (Coagulation) Analyzer Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Hemostasis (Coagulation) Analyzer Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Hemostasis (Coagulation) Analyzer Market:
(Note: The list of the major players will be updated with the latest market scenario and trends)
Hemostasis (Coagulation) Analyzer Market Segmentation:
By Product
By Test
By Technology
By End Users
By Region
Competitive Landscape:
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Hemostasis (Coagulation) Analyzer Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Hemostasis (Coagulation) Analyzer Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Hemostasis (Coagulation) Analyzer Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Hemostasis (Coagulation) Analyzer Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Clinical Laboratory Analyzers 7.2. Systems 7.2.1. Automated Systems 7.2.2. Semi-automated Systems 7.2.3. Manual Systems 7.3. Consumables 7.3.1. Reagents 7.3.2. Standards, Controls and Calibrations 7.4. Analyzers for Point-of-Care Testing 8. Global Hemostasis (Coagulation) Analyzer Market, By Test Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Prothrombin Time 8.2. Fibrinogen 8.3. Activated Partial Thromboplastin Time 8.4. Activated Clotting Time 8.5. D Dimer 8.6. Platelet Function 8.7. Anti-factor Xa 8.8. Heparin & Protamine Dose Response Test for ACT 8.9. Other Coagulation Tests 9. Global Hemostasis (Coagulation) Analyzer Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Mechanical 9.2. Optical 9.3. Electrochemical 9.4. Other Technologies 10. Global Hemostasis (Coagulation) Analyzer Market, By End Users Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Clinical Laboratories 10.2. POC 10.3. Others End Users 11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2020-2027 12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Regional Market Trends 12.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.3.1. Brazil 12.3.2. Venezuela 12.3.3. Argentina 12.3.4. Rest of Latin America 12.4. Market Size (USD Million) Forecast for Latin America 2020-2027 13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Switzerland 13.2.9. Rest of Western Europe 14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Japan 14.2.2. China 14.2.3. Singapore 14.2.4. India 14.2.5. Australia and New Zealand 14.2.6. ASEAN 14.2.7. South Korea 14.2.8. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Saudi Arabia 15.2.2. UAE 15.2.3. South Africa 15.2.4. Egypt 15.3. Market Size (USD Million) Forecast for MEA 2020-2027 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Technology Portfolio, Financial Layouts) 16.1. Alere Inc. 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Nihon Kohden Corporation 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.) 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Siemens Healthcare (A Division of Siemens AG) 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Sysmex Corporation 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Thermo Fisher Scientific Inc. 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Diagnostica Stago Sas 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Helena Laboratories 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Instrumentation Laboratory (A Division of the Werfen Group) 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10. International Technidyne Corporation (ITC) 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 17. FutureWise SME key takeaway points for Client
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders
2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study
3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Hemostasis (Coagulation) Analyzer Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Hemostasis (Coagulation) Analyzer Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Hemostasis (Coagulation) Analyzer Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Hemostasis (Coagulation) Analyzer Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Clinical Laboratory Analyzers 7.2. Systems 7.2.1. Automated Systems 7.2.2. Semi-automated Systems 7.2.3. Manual Systems 7.3. Consumables 7.3.1. Reagents 7.3.2. Standards, Controls and Calibrations 7.4. Analyzers for Point-of-Care Testing
8. Global Hemostasis (Coagulation) Analyzer Market, By Test Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Prothrombin Time 8.2. Fibrinogen 8.3. Activated Partial Thromboplastin Time 8.4. Activated Clotting Time 8.5. D Dimer 8.6. Platelet Function 8.7. Anti-factor Xa 8.8. Heparin & Protamine Dose Response Test for ACT 8.9. Other Coagulation Tests
9. Global Hemostasis (Coagulation) Analyzer Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Mechanical 9.2. Optical 9.3. Electrochemical 9.4. Other Technologies
10. Global Hemostasis (Coagulation) Analyzer Market, By End Users Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Clinical Laboratories 10.2. POC 10.3. Others End Users
11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2020-2027
12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Regional Market Trends 12.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.3.1. Brazil 12.3.2. Venezuela 12.3.3. Argentina 12.3.4. Rest of Latin America 12.4. Market Size (USD Million) Forecast for Latin America 2020-2027
13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Switzerland 13.2.9. Rest of Western Europe
14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Japan 14.2.2. China 14.2.3. Singapore 14.2.4. India 14.2.5. Australia and New Zealand 14.2.6. ASEAN 14.2.7. South Korea 14.2.8. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Saudi Arabia 15.2.2. UAE 15.2.3. South Africa 15.2.4. Egypt 15.3. Market Size (USD Million) Forecast for MEA 2020-2027
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Technology Portfolio, Financial Layouts) 16.1. Alere Inc. 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Nihon Kohden Corporation 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.) 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Siemens Healthcare (A Division of Siemens AG) 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Sysmex Corporation 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Thermo Fisher Scientific Inc. 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Diagnostica Stago Sas 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Helena Laboratories 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Instrumentation Laboratory (A Division of the Werfen Group) 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10. International Technidyne Corporation (ITC) 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 17. FutureWise SME key takeaway points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics